Concepedia

Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide

Jiao-Yu Zhao, Si‐Ning Liu, Lan‐Ping Xu, Xiaohui Zhang, Yu Wang, Yu‐Hong Chen, Kai‐Yan Liu, Xiao‐Jun Huang, Xiao‐Dong Mo

Annals of Hematology · 2020 · 22 citations · 54 references

DOI

Concepts

References

54

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Madan Jagasia, Hildegard Greinix, Mukta Arora et al. · Biology of Blood and Marrow Transplantation · 2014 · 5.4K citations · Full text

, , +9

1994 Consensus Conference on Acute GVHD Grading.

Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed · 1995 · 5.1K citations

, , +6

Bone marrow transplant

Angela Joyce · Paediatric Care · 1989 · 3.4K citations

, , +11

Bone marrow transplant

The Medical Journal of Australia · 1999 · 3.4K citations

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali et al. · New England Journal of Medicine · 2012 · 1.8K citations · Full text

, , +10